"Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study"

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

October 25, 2026

Study Completion Date

April 25, 2027

Conditions
Atherosclerosis of Coronary Artery
Interventions
DIAGNOSTIC_TEST

Single Cell RNA Sequencing

"Reprocessing~Data normalization, dimensionality reduction, and clustering will be performed using the Seurat package (based on R).~Cell types will be identified based on canonical marker gene expression. Cell Subpopulation Identification~Clusters will be annotated based on signatures of known cell types (e.g., endothelial cells, smooth muscle cells, macrophages, etc.).~Differential gene expression analysis will be conducted to identify disease-associated genes.~Pathway and Function Enrichment~Gene Set Enrichment Analysis (GSEA) and pathway analyses (e.g., KEGG, Reactome) will be carried out to investigate the biological processes and pathways driving atherosclerosis.~Quality Control~Sequencing reads will be assessed for quality using FASTQC, and low-quality reads will be filtered out.~The Cell Ranger software (10x Genomics) will be used to align reads to the human genome and quantify gene expression at the single-cell level."

Trial Locations (1)

05652-900

Hospital Israelita Albert Einstein, São Paulo

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER

NCT06860295 - "Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study" | Biotech Hunter | Biotech Hunter